Vitale, M; Zamai, L; Falcieri, E et al. (1997) IMP dehydrogenase inhibitor, tiazofurin, induces apoptosis in K562 human erythroleukemia cells. Cytometry 30:61-6
|
Look, K Y; Moore, D H; Sutton, G P et al. (1997) Increased thymidine kinase and thymidylate synthase activities in human epithelial ovarian carcinoma. Anticancer Res 17:2353-6
|
Olah, E; Csokay, B; Prajda, N et al. (1996) Molecular mechanisms in the antiproliferative action of taxol and tiazofurin. Anticancer Res 16:2469-77
|
Zamai, L; Zauli, G; Bavelloni, A et al. (1995) Tiazofurin induces a down-modulation of ICAM-1 expression on K562 target cells impairing NK adhesion and killing. Cell Immunol 164:100-4
|
Singhal, R L; Yeh, Y A; Look, K Y et al. (1994) Coordinated increase in activities of the signal transduction enzymes PI kinase and PIP kinase in human cancer cells. Life Sci 55:1487-92
|
Rizzo, M T; Weber, G (1994) 1-Phosphatidylinositol 4-kinase: an enzyme linked with proliferation and malignancy. Cancer Res 54:2611-4
|
Weber, G; Hata, Y; Prajda, N (1994) Role of differentiation induction in action of purine antimetabolites. Pharm World Sci 16:77-83
|
Hata, Y; Sandler, A; Loehrer, P J et al. (1994) Synergism of taxol and gallium nitrate in human breast carcinoma cells: schedule dependency. Oncol Res 6:19-24
|
Weber, G; Prajda, N (1994) Targeted and non-targeted actions of anti-cancer drugs. Adv Enzyme Regul 34:71-89
|
Yeh, Y A; Olah, E; Wendel, J J et al. (1994) Synergistic action of taxol with tiazofurin and methotrexate in human breast cancer cells: schedule-dependence. Life Sci 54:PL431-5
|
Showing the most recent 10 out of 78 publications